Hmong
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message
Tirzepatide GMP DMF Qib: Cov Khoom Siv Raw Siab Rau Pharma & Nutraceuticals
Tshuaj Peptide
telpoeptide.png

Tirzepatide GMP DMF Qib: Cov Khoom Siv Raw Siab Rau Pharma & Nutraceuticals

daim ntawv pov thawj_03

Tirzepatide yog ib yam tshuaj tshiab uas muaj ob hom kev ua haujlwm uas tsom mus rau ob qho tib si glucose-dependent insulinotropic polypeptide (GIP) thiab glucagon-zoo li peptide-1 (GLP-receptors). Tsim tawm raws li Kev Ua Haujlwm Zoo (GMP) nrog kev txhawb nqa Drug Master File (DMF), Tirzepatide sawv tawm ua thawj zaug hauv chav kawm kev kho mob. Kev kho mob tshiab no muaj kev ua haujlwm zoo tshaj plaws hauv kev tswj cov ntshav qab zib thiab txhawb kev poob phaus zoo los ntawm kev siv nws txoj kev ua haujlwm tshwj xeeb. Tshawb nrhiav seb Tirzepatide tuaj yeem hloov pauv kev tswj ntshav qab zib thiab kev rog dhau rau cov txiaj ntsig kev noj qab haus huv zoo dua.

    Tiv tauj peb
    cov ntsiab lus ntawm cov khoom

    piav qhia1

    Kev piav qhia txog khoom

    Tirzepatide GMP DMF qib yog ib qho peptide purity siab tsim tawm raws li cov qauv tsim tshuaj nruj. Nws ua haujlwm ua ob lub GIP thiab GLP-1 receptor agonist, muab cov txiaj ntsig metabolic zoo dua piv rau ib lub receptor agonists. Cov khoom lag luam muaj kev ruaj khov zoo heev, kev sib xws ntawm cov khoom, thiab kev ua raws li txoj cai, ua rau nws yog cov khoom xyaw tshuaj zoo tshaj plaws rau kev kho mob metabolic siab heev.

    111
    Telpoeptide

    Cov cwj pwm

    Lub Npe Lus Askiv Tirzepatide Qhov Ceev
    CAS TSIS MUAJ 1414664-00-3 Kev Ruaj Ntseg Ruaj khov hauv lub xeev lyophilized (kaw, -20 ℃ txog -80 ℃); tsis txhob rov ua dua cov voj voog khov-thaw, cov tshuaj oxidants muaj zog, thiab cov xwm txheej pH hnyav.
    Cov Qauv Molecular C₂₂₁H₃₄₈N₆₂O₇₀S₆ Kev Khaws Cia Kaw, tiv taus lub teeb, thiab tiv taus dej noo; khaws cia ntawm -20 ℃ txog -80 ℃ hauv cov chaw ua raws li GMP
    Mol.wt. 5123.6 Kev yaj tau Yaj hauv dej (≥15 mg / mL ntawm 25 ℃), me ntsis yaj hauv methanol
    EINECS No. Tsis muaj Daim Ntawv Hmoov
    MDL No. MFCD34192689 Xim Dawb rau offwhite lyophilized hmoov
    Qhov Kub Yaj Decomposes saum toj no 210 ℃ (lyophilized daim ntawv) Tus nqi pH 4.0-6.0 (0.1% kua dej)
    kg

    Cov Txiaj Ntsig Tseem Ceeb rau Kev Noj Qab Haus Huv

    Cov Txheej Txheem Ua Haujlwm

    Metabolic-Syndrome-thiab-Diabetes
    Kev Tswj Xyuas Glycemic Zoo Tshaj Plaws
    Muab cov teebmeem txo qis qabzib los ntawm kev siv ob lub GIP thiab GLP-1 receptor agonism, ua rau HbA1c txo qis ntau dua li ib lub GLP-1 receptor agonists.
    2222
    Kev Txo Qhov Hnyav Tseem Ceeb
    Qhia tau tias lub cev poob phaus ntau thiab nyob ntawm qhov koob tshuaj, ua tau zoo dua li cov kev kho mob GLP-1 uas twb muaj lawm hauv kev tshawb fawb hauv tsev kho mob.
    Kev Tiv Thaiv Kab Mob Plawv
    Cov txiaj ntsig ntawm kev kho mob plawv thiab lub hlwb
    Txhim kho ntau yam kev ntsuas cardiometabolic suav nrog ntshav siab, lipid profiles, thiab cov rog hauv siab, muab kev tiv thaiv metabolic tag nrho.

    Cov ntawv thov

    tes-nrog-hnab-tiv-thaiv-tuav-cov-ntshav-kuaj-covid_23-2148958363
    01
    Kev Kho Mob Ntshav Qab Zib
    API tseem ceeb rau cov tshuaj txhaj uas tsom mus rau kev kho mob ntshav qab zib hom 2, tshwj xeeb tshaj yog rau cov neeg mob uas xav tau kev tswj hwm glycemic thiab kev tswj hwm qhov hnyav.
    Cov Neeg Nyiam Kev Noj Qab Haus Huv
    01
    Kev Tswj Xyuas Kev Rog Phem
    Cov khoom tseem ceeb hauv cov khoom siv tshuaj tsim los rau kev tswj qhov hnyav mus ntev rau cov neeg mob uas muaj lossis tsis muaj ntshav qab zib hom 2.
    Ua tus thawj coj rau yav tom ntej ntawm Biobeauty nrog G-Med Group thiab Shaanxi Bieyouth Biotech Co.
    03
    Kev Kho Mob Metabolic Syndrome
    Cov khoom xyaw tseem ceeb hauv kev kho mob ua ke uas hais txog ntau yam ntawm cov kab mob metabolic syndrome, suav nrog kev tsis kam insulin thiab cov teeb meem cuam tshuam.

    Kev Tswj Xyuas Zoo

    Peb ua raws li cov qauv tswj xyuas zoo kom ntseeg tau tias peb cov Tirzepatide ua tau raws li cov qauv siab tshaj plaws ntawm kev huv thiab kev ua haujlwm zoo. Txhua pawg raug kuaj xyuas kom paub tseeb tias muaj cov khoom xyaw nquag thiab los tshuaj xyuas cov khoom muaj kuab paug.

    daim ntawv pov thawj1
    daim ntawv pov thawj2
    daim ntawv pov thawj3
    daim ntawv pov thawj4
    daim ntawv pov thawj5
    daim ntawv pov thawj6
    daim ntawv pov thawj7
    daim ntawv pov thawj8
    0102030405060708
    1

    Txog Peb

    Shaanxi Bieyouth Biotech Co., Ltd. zoo siab los muab Tirzepatide, ib qho tshuaj ntxiv tshiab rau cov neeg uas xav txhim kho lawv txoj kev noj qab haus huv ntawm lub cev thiab tiv thaiv kev puas tsuaj ntawm lub sijhawm. Los ntawm kev koom ua ke peb cov Tirzepatide rau hauv koj txoj kev noj qab haus huv, koj tab tom ua ib kauj ruam tseem ceeb los tiv thaiv koj lub cev cov hlwb thiab txhawb kom muaj lub neej ntev dua thiab noj qab haus huv dua. Paub txog lub zog ntawm cov tshuaj antioxidant zoo no thiab txais tos cov txiaj ntsig ntawm Tirzepatide rau koj txoj kev noj qab haus huv.
    txog

    sendinquiry